WordNet

to remain unmolested, undisturbed, or uninterrupted -- used only in infinitive form; "let her be"
work in a specific place, with a specific subject, or in a specific function; "He is a herpetologist"; "She is our resident philosopher" (同)follow
have life, be alive; "Our great leader is no more"; "My grandfather lived until the end of war" (同)live
be identical to; be someone or something; "The president of the company is John Smith"; "This is my house"
happen, occur, take place; "I lost my wallet; this was during the visit to my parents house"; "There were two hundred people at his funeral"; "There was a lot of noise in the kitchen"
have the quality of being; (copula, used with an adjective or a predicate noun); "John is rich"; "This is not a good answer"
occupy a certain position or area; be somewhere; "Where is my umbrella?" "The toolshed is in the back"; "What is behind this behavior?"
spend or use time; "I may be an hour"
stake on the outcome of an issue; "I bet $100 on that new horse"; "She played all her money on the dark horse" (同)wager, play
the act of gambling; "he did it on a bet" (同)wager
maintain with or as if with a bet; "I bet she will be there!" (同)wager
second in order of importance; "the candidate, considered a beta male, was perceived to be unable to lead his party to victory"
the 2nd letter of the Greek alphabet
preliminary or testing stage of a software or hardware product; "a beta version"; "beta software"
(microbiology) single-celled or noncellular spherical or spiral or rod-shaped organisms lacking chlorophyll that reproduce by fission; important as pathogens and for biochemical properties; taxonomy is difficult; often considered to be plants (同)bacterium

PrepTutorEJDIC

《連結語として補語を伴なって…『である』,…だ,…です / 《位置・場所を表す語句を伴って》(…に)『ある』,いる(occupy a place or situation) / 〈物事が〉『存在する』,ある(exist);〈生物が〉生存する,生きている(live) / 行われる,起こる,発生する(take place, occur) / 存続する,そのままでいる(remain as before) / 《『be to』 do》 / …する予定である,…することになっている / …すべきだ / 《受動態の不定詞を伴って》…できる / 《命令》…するのだ / 《条件節に》…する意図がある / 《『if…were to』 do》…するとしたなら / 《『be』 do『ing』》《進行形》 / 《進行中の動作》…している,しつつある / 《近い未来》…しようとしている,するつもり / 《動作の反復》(いつも)…している / 《『be』+『他動詞の過去分詞』》《受動態》…される,されている / 《『be』+『自動詞の過去分詞』》《完了形》…した[状態にある]
『かけ』・(…との)かけ《+『with』+『名』》 / かけた物(金) / かけの対象 / 〈金・物〉'を'『かける』 / (かけ事・ゲームなどで)〈人〉‘と'『かけをする』《+『名』〈人〉+『on』+『名』》 / (…に)『かける』《+『on』(『against』)+『名』(one's do『ing』)》
ベータ(ギリシア語アルファベットの第2文字;B,β;英語のB,b に遭当)
『バクテリア』,細菌
americiumの化学記号

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. カルバペネマーゼ産生グラム陰性桿菌の概要 overview of carbapenemase producing gram negative bacilli
2. 基質特異性拡張型β-ラクタマーゼ extended spectrum beta lactamases
3. β-ラクタマーゼ阻害剤、カルバペネム系、およびモノバクタム系抗菌薬の併用 combination beta lactamase inhibitors carbapenems and monobactams
4. β-ラクタム系抗生物質：作用機序、耐性および有害作用 beta lactam antibiotics mechanisms of action and resistance and adverse effects
5. セラチア種による感染症 infections due to serratia species

English Journal

Detection of expanded-spectrum β-lactamases in Gram-negative bacteria in the 21st century.

Al-Bayssari C1, Dabboussi F, Hamze M, Rolain JM.
Expert review of anti-infective therapy.Expert Rev Anti Infect Ther.2015 Jul 10:1-20. [Epub ahead of print]
Emerging β-lactamase-producing-bacteria (ESBL, AmpC and carbapenemases) have become a serious problem in our community due to their startling spread worldwide and their ability to cause infections which are difficult to treat. Diagnosis of these β-lactamases is of clinical and epidemiological inte
PMID 26162631

OP0595, a new diazabicyclooctane: mode of action as a serine β-lactamase inhibitor, antibiotic and β-lactam 'enhancer'.

Morinaka A1, Tsutsumi Y2, Yamada M2, Suzuki K2, Watanabe T2, Abe T2, Furuuchi T2, Inamura S2, Sakamaki Y2, Mitsuhashi N2, Ida T2, Livermore DM3.
The Journal of antimicrobial chemotherapy.J Antimicrob Chemother.2015 Jun 18. pii: dkv166. [Epub ahead of print]
OBJECTIVES: The production of a growing diversity of β-lactamases by Gram-negative bacteria challenges antimicrobial chemotherapy. OP0595, discovered separately by each of Meiji Seika Pharma and Fedora Pharmaceuticals, is a new diazabicyclooctane serine β-lactamase inhibitor that also acts as an a
PMID 26089439

High prevalence of CTX-M-15 and first report of CTX-M-3, CTX-M-22, CTX-M-28 and plasmid-mediated AmpC beta-lactamase producing Enterobacteriaceae causing urinary tract infections in Bosnia and Herzegovina in hospital and community settings.

Ibrahimagić A1, Bedenić B2, Kamberović F3, Uzunović S4.
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.J Infect Chemother.2015 May;21(5):363-9. doi: 10.1016/j.jiac.2015.01.003. Epub 2015 Jan 9.
AIM: To investigate molecular epidemiology of extended-spectrum β-lactamase/ESBL and plasmid-mediated AmpC β-lactamase/pAmpC producing Gram-negative bacteria causing urinary tract infections (UTIs) in Zenica-Doboj Canton, Bosnia and Herzegovina, in the period Decembar 2009-May 2010.METHODS: Antibi
PMID 25638292

Japanese Journal

β‐ｌａｃｔａｍａｓｅ産生菌の細菌学的研究　　薬剤耐性と臨床動態:薬剤耐性と臨床動態

金聖眞,玉置弘光,松岡喜美子,金廣郁子
日本耳鼻咽喉科学会会報 91(11), 1883-1891, 1988
… to β-lactamase-producing organisms which hydrolyze these antibiotics.We have recently screened pathogenic organisms, which have been isolated clinically from the urine, blood, sputum and pus of patients treated at various specialities of our hospital including otorhinolaryngology, for chronological incidence of β-lactamase-producing strains by acidimetric and nitrocephin methods.We have also studied current activity of amoxillin (AMPC) and …
NAID 130000808487